Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 23, 2016 08:03 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Provides Corporate and Financial Update

~ Expands Rare Disease Portfolio through Acquisition of U.S. Rights to KEVEYIS®, the First and Only FDA-Approved Treatment for Hyperkalemic, Hypokalemic, and Related Variants of Primary Periodic...
December 23, 2016 08:01 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Acquisition of U.S. Rights to KEVEYIS® From Taro

~ KEVEYIS is the First and Only FDA-Approved Treatment for Hyperkalemic, Hypokalemic, and Related Variants of Primary Periodic Paralysis, an Ultra-Orphan, Genetic Neuromuscular Disease ~ ~ KEVEYIS is...
December 23, 2016 08:00 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces $35 Million Equity Financing

DUBLIN, Ireland and TREVOSE, Pa., Dec. 23, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and...
November 29, 2016 08:00 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Promotion of Fredric Cohen, M.D., to Chief Medical Officer

DUBLIN, Ireland and TREVOSE, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global biopharmaceutical company focused on the development and commercialization of...
October 03, 2016 08:00 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Appointment of Jeffrey W. Sherman, M.D., FACP, to Board of Directors

DUBLIN, Ireland and TREVOSE, Pa., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global biopharmaceutical company focused on the development and commercialization...
July 06, 2016 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., July 06, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutical company focused on the development and...
June 14, 2016 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc to Participate in the JMP Securities Life Sciences Conference and 3rd Annual ROTH Healthcare Day in London

DUBLIN, Ireland and TREVOSE, Pa., June 14, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutical company focused on the development and...
June 09, 2016 16:15 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Executive Promotion and Leadership Transition

DUBLIN, Ireland and TREVOSE, Pa., June 09, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP), a global rare disease biopharmaceutical company focused on the development and...
June 02, 2016 16:05 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation at Jefferies 2016 Healthcare Conference

DUBLIN, Ireland and TREVOSE, Pa., June 02, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutical company focused on the development and...
May 31, 2016 07:30 ET | Source: Strongbridge Biopharma plc

Strongbridge Biopharma plc Announces Presentation of COR-003 and COR-005 Data at the European Congress of Endocrinology

DUBLIN, Ireland and TREVOSE, Pa., May 31, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (Nasdaq:SBBP), a global rare disease biopharmaceutical company focused on the development and...